Polypharmacy in nursing home residents with severe cognitive impairment: results from the SHELTER Study.
about
Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer's disease clinical trialsFactors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study.Recommendations to prescribe in complex older adults: results of the CRIteria to assess appropriate Medication use among Elderly complex patients (CRIME) project.Polypharmacy, potentially inappropriate medication and cognitive status in Austrian nursing home residents: results from the OSiA study.Association between polypharmacy and cognitive impairment in an elderly Japanese population residing in an urban community.Development and application of medication appropriateness indicators for persons with advanced dementia: a feasibility study.Association between polypharmacy and multiple uses of medical facilities in nursing home residents.A Systematic Review of Practice Guidelines and Recommendations for Discontinuation of Cholinesterase Inhibitors in Dementia.Role of anticholinergic burden in primary care patients with first cognitive complaints.Poor adherence to chronic obstructive pulmonary disease medications in primary care: Role of age, disease burden and polypharmacy.Association of sarcopenia with short- and long-term mortality in older adults admitted to acute care wards: results from the CRIME study.The epidemiology of polypharmacy in older adults: register-based prospective cohort study.Building interpretable models for polypharmacy prediction in older chronic patients based on drug prescription records
P2860
Q36285087-A1E776FF-5A20-43AD-BFB6-5FC5D6F1368DQ36773303-63D6D301-8C03-457D-8D96-6FD8531AFE2FQ38162813-35FB94B9-E976-4778-9366-084CE25460E0Q40022019-672821A9-C3BD-453B-9734-353429E53CB6Q40404771-ECE1C151-DC08-46BC-B5D0-46327256096FQ41722511-6B0735CA-D583-4D14-89DA-C4EED61B9D47Q44647787-75BEA0D6-00F5-43A6-A451-CE1E154CC6FBQ47571627-DC37FAEC-8E12-46E9-8ED6-F8EF5D6376FEQ47723092-1FF0022F-A209-432C-9178-E82CDEAB2951Q48213382-30A9DEF7-DA2E-47AB-93B1-DE8876F4F54BQ51093278-5437CB43-8BC4-4D67-B470-0FB82DD7A6AFQ51761139-A201FB72-50FE-4251-BBE0-FF48AD4C2871Q57815635-075DC6C6-2B80-476B-849C-DABCCDEC43ED
P2860
Polypharmacy in nursing home residents with severe cognitive impairment: results from the SHELTER Study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Polypharmacy in nursing home r ...... esults from the SHELTER Study.
@en
Polypharmacy in nursing home r ...... esults from the SHELTER Study.
@nl
type
label
Polypharmacy in nursing home r ...... esults from the SHELTER Study.
@en
Polypharmacy in nursing home r ...... esults from the SHELTER Study.
@nl
prefLabel
Polypharmacy in nursing home r ...... esults from the SHELTER Study.
@en
Polypharmacy in nursing home r ...... esults from the SHELTER Study.
@nl
P2093
P50
P1476
Polypharmacy in nursing home r ...... results from the SHELTER Study
@en
P2093
Daniela Fialova
Francesco Landi
Giuseppe Colloca
Graziano Onder
Jacob Gindin
Rosa Liperoti
SHELTER Study
P304
P356
10.1016/J.JALZ.2012.09.009
P577
2012-12-08T00:00:00Z